Perrigo announced that it has received tentative approval from the Food and Drug Administration (FDA) for Sodium Sulfate/Potassium Sulfate/Magnesium Sulfate Oral Solution, the generic version of ...

* Perrigo announces tentative FDA approval for generic version of Suprep oral solution and confirms patent challenge for generic version of Mirvaso gel * Was sued by Galderma Laboratories LP and ...

Strides Pharma has obtained the Food and Drug Administration’s approval for two generics. Strides’ subsidiary, Strides Pharma Global, Singapore, has received approval from the FDA for Sodium Sulphate, ...

New Delhi, Sep 9 (PTI) Pharmaceuticals firm Lupin Ltd on Friday said it has launched the generic sodium sulfate, potassium sulfate and magnesium sulfate oral solution, used for cleansing colon as a ...

The drug will be available in one strength with a fixed dose to be taken once daily. (File) Global pharma major Lupin Limited on Friday announced the launch of Sodium Sulfate, Potassium Sulfate, and ...

India’s second largest pharmaceutical major Lupin announced on Tuesday that the US Food and Drug Administration had granted it approval to market the generic version of Braintree Laboratories’ Suprep ...

The said drug is an equivalent generic version of Suprep Bowel prep kit oral solution. Sodium sulfate, potassium sulfate, and magnesium sulfate combination is used to cleanse the colon (bowel) before ...

SILVER SPRING, Md. — The Food and Drug Administration has approved Perrigo’s generic of Suprep (sodium sulfate/potassium sulfate/magnesium sulfate) oral solution, the company announced Tuesday. The ...

Lupin Ltd has informed BSE regarding a Press Release dated February 28, 2017 titled "Lupin Receives FDA Approval for Generic Suprep Advisory Alert: It has come to our attention that certain ...

Lupin Limited has announced the launch of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, having received an approval from the United States ...